Assessment of treatment adherence in patients receiving acenocoumarol in a telecare program
DOI:
https://doi.org/10.60103/phc.v27.e886Keywords:
telemedicine; acenocumarol; adherence; pharmacotherapeutic monitoringAbstract
Introduction: Adherence to treatment with oral anticoagulants is essential to ensure the effectiveness and safety of the therapy. This study evaluates therapeutic adherence in patients treated with acenocoumarol using the Morisky-Green questionnaire, the patient's experience with the IEXPAC instrument and the safety in the use of this drug.
Method: A study was carried out with patients over 18 years of age with cardiovascular disease treated with acenocoumarol, included in a programmed delivery program and telepharmacy follow-up. A retrospective review of medical records was performed to evaluate adherence to treatment and hospitalizations in 2023 and 2024. Prospectively, structured telephone interviews were conducted to evaluate adherence and satisfaction with the care received.
Results: Ten patients prescribed acenocoumarol were included (7 men and 3 women with a mean age of 57 years, from a registry of 179 patients). 81% discontinued the medication quarterly and all had INR controls; one patient was hospitalized in 2024 for treatment-associated hematuria. Regarding the results of the telephone interviews, 87.5% identified their cardiologist and showed adherence, 63.5% did not recognize the warning signs of treatment, 87.5% expressed satisfaction with the care received and only 70% received information on diet and medications. This last aspect highlights the need to strengthen health education, which is why a workshop for patients was organized and an educational brochure was developed.
Conclusions: High adherence was identified although there is a lack of information on the safety of the use of oral anticoagulants. Satisfaction with care was high.
Downloads
References
Jacob, V, Reynolds, JA, Chattopadhyay, SK, Hopkins, DP, Therrien, NL, Jones, CD, Durthaler, JM, Rask, KJ, Cuellar, AE, Clymer, JM, Kottke, TE, & Community Preventive Services Task Force (CPSTF). Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease. American journal of preventive medicine, 2022, Mar; 62(3):e202–e222. https://doi.org/10.1016/j.amepre.2021.08.021
Simon, ST, Kini, V, Levy, AE, Ho, PM. Medication adherence in cardiovascular medicine. BMJ, 2021, Aug 11;374:n1493. doi: 10.1136/bmj.n1493
Puigdemont, NP, Valverde-Merino, MI. Adherencia terapéutica: factores modificadores y estrategias de mejora. Ars Pharm. 2018;59(4):251–8. doi: 10.30827/ars.v59i4.7357
Torres Celi D, Solano Rubio Y. Percepción de la calidad de atención en servicios de salud del área de materno infantil. Cienc Lat Salud. 2024;8(1):5678–96. doi: 10.37811/cl_rcm.v8i1.9921
Brandariz-Núñez, D, Ferreiro-Gómez, M, Suanzes, J, Margusino-Framiñán, L, De la Cámara-Gómez, M, Fandiño-Orgueira JM, et al. Prevalence of adverse drug reactions associated with emergency department visits and risk factors for hospitalization. Farm Hosp. 2023;47:20–5. doi: 10.1016/j.farma.2022.10.002
Goienetxea, E. Seguimiento farmacoterapéutico: competencia del farmacéutico. Farm Comunitarios. 2017;9(4):14–7. doi: 10.5672/FC.2173-9218.(2017/Vol9).004.03
Leal, B, Torres, H, Roco, Á, Román, R, Rojo, M, Nieto, E, et al. Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular. Rev Med Chil. 2021;149(5):724–32. doi:10.4067/S0034-98872021000500724
Hussain, A, Bowen, AM. Exploring Pharmacist Roles in Telepharmacy for Chronic Disease Management in New York State: A Qualitative Inquiry into Improving Implementation, Patient Communication, and Healthcare Technology Support. Cureus. 2024 Jun 23;16(6):e62982. doi: 10.7759/cureus.62982
Pagès-Puigdemont, N, Valverde-Merino, MI. Métodos para medir la adherencia terapéutica. Ars Pharm [Internet]. 2018 Sep [citado 2025 Abr 27];59(3):163–72. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2340-98942018000300163
Mira, JJ, Nuño-Solinís, R, Guilabert, M, Solas, O, Fernández-Cano, P, González-Mestre, MA, et al. Development and validation of an instrument for assessing patient experience of chronic illness care. Int J Integr Care, 2016;16(3):13. doi: 10.5334/ijic.2446
Iglesias, DC, García Martín, S, Casas Sepúlveda, RM, Martín Ballesteros, CP, Villarín Castro, A. Cumplimiento terapéutico en pacientes en tratamiento con anticoagulantes orales en Atención Primaria. Rev Clin Med Fam [Internet], 2021 [citado 2025 Feb 18];14(1):12–7. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2021000100012
Rubio-Armendáriz, C, Alberto-Armas, D, Plasín-Rodríguez, MG, Padrón-Fuentes, CC, Casanova-Herrera, NR, González-González, MY. Acenocumarol: uso, adherencia y conocimiento del usuario. Oportunidades para la Atención Farmacéutica. JONNPR [Internet], 2021 [citado 2025 Abr 27];6(12):1427–45. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2529-850X2021001200002
Martínez de Morentin de Benito, LM, Treceño Lobato, C, Valles Martín, E. Valoración de la incidencia de PRM/RNM en pacientes tratados con anticoagulantes orales y evaluación de la intervención farmacéutica en farmacia comunitaria. FarmaJournal, 2023;8(1):33–47. doi: 10.14201/fj2023813347
Sáez-Benito, A. Papel del farmacéutico en la atención al paciente en tratamiento con anticoagulantes orales. Pharm Care Esp [Internet], 2022 [citado 2025 Abr 27];24(Supl 1):43–5. Disponible en: https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/695
Sáez-Benito, AM, Sáez-Benito, L, Salazar, M, Magallón, R, Berenguer, N. The role of the pharmacist in a patient's care for individuals undergoing anticoagulant therapy: a case report. Life (Basel), 2024;14(8):986. doi: 10.3390/life14080986. PMID: 39202728; PMCID: PMC11355091
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pamela Bertoldo, Gina Rinaldini, Perla Valeria Catube
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).
